Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East.

IF 2.6 4区医学 Q2 ONCOLOGY

Future oncology Pub Date : 2025-09-12 DOI:10.1080/14796694.2025.2548192

Deborah Mukherji, Mohit Agarwal, Humaid O Al-Shamsi, Martin Angel, Diogo Augusto Rodrigues Da Rosa, Sewanti Limaye, Vikas Talreja, Waleed El Morsi, Yüksel Ürün, Enrique Grande

{"title":"Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East.","authors":"Deborah Mukherji, Mohit Agarwal, Humaid O Al-Shamsi, Martin Angel, Diogo Augusto Rodrigues Da Rosa, Sewanti Limaye, Vikas Talreja, Waleed El Morsi, Yüksel Ürün, Enrique Grande","doi":"10.1080/14796694.2025.2548192","DOIUrl":null,"url":null,"abstract":"Aims: Guidance and regulation for the use of social media (SM) by healthcare professionals (HCPs) is lacking in some parts of the world. This paper explores the significance and barriers of SM in oncology care in regions beyond Europe and North America.Methods: A cross-sectional survey facilitated by Sermo to explore the use of SM among oncologists in Argentina, Brazil, India, Mexico, Saudi Arabia, Taiwan, Türkiye, and the United Arab Emirates was conducted between 14 June 2023 and 28 June 2023. A panel discussion involving seven digital opinion leaders (DOLs) was also held.Results: Of 340 respondents, the survey found strong support for SM in public and HCP education with most preferring mobile phones and 88% accessing SM in their free time. SM has an average-to-great impact on the prescribing habits of 52% of respondents. Sixty-four percent of respondents are concerned about potential conflicts of interest with SM. The panel developed a framework of recommendations providing navigational aids for key information, verifying sources to avoid misinformation, disclosing conflicts of interests, and creating visual and bite-sized content.Conclusion: Opportunities exist to enhance SM use in regions beyond Europe and North America. DOLs in oncology can enhance SM content quality.","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"1-14"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2025.2548192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: Guidance and regulation for the use of social media (SM) by healthcare professionals (HCPs) is lacking in some parts of the world. This paper explores the significance and barriers of SM in oncology care in regions beyond Europe and North America.

Methods: A cross-sectional survey facilitated by Sermo to explore the use of SM among oncologists in Argentina, Brazil, India, Mexico, Saudi Arabia, Taiwan, Türkiye, and the United Arab Emirates was conducted between 14 June 2023 and 28 June 2023. A panel discussion involving seven digital opinion leaders (DOLs) was also held.

Results: Of 340 respondents, the survey found strong support for SM in public and HCP education with most preferring mobile phones and 88% accessing SM in their free time. SM has an average-to-great impact on the prescribing habits of 52% of respondents. Sixty-four percent of respondents are concerned about potential conflicts of interest with SM. The panel developed a framework of recommendations providing navigational aids for key information, verifying sources to avoid misinformation, disclosing conflicts of interests, and creating visual and bite-sized content.

Conclusion: Opportunities exist to enhance SM use in regions beyond Europe and North America. DOLs in oncology can enhance SM content quality.

查看原文本刊更多论文

肿瘤学医疗保健专业人员的社交媒体：来自亚洲、拉丁美洲和中东八个国家的横断面调查结果。

目的：世界上一些地区缺乏对医疗保健专业人员（HCPs）使用社交媒体（SM）的指导和监管。本文探讨了SM在欧洲和北美以外地区肿瘤治疗中的意义和障碍。方法：在2023年6月14日至2023年6月28日期间，由Sermo组织的一项横断面调查探讨了阿根廷、巴西、印度、墨西哥、沙特阿拉伯、台湾、土耳其和阿拉伯联合酋长国的肿瘤学家使用SM的情况。此外，亦有七位数码意见领袖参与小组讨论。结果：在340名受访者中，调查发现在公共和HCP教育中，SM得到了强烈的支持，大多数人更喜欢手机，88%的人在空闲时间使用SM。SM对52%的受访者的处方习惯有中等到很大的影响。64%的受访者担心与SM的潜在利益冲突。该小组制定了一个建议框架，为关键信息提供导航辅助，核实来源以避免错误信息，披露利益冲突，以及创建可视化和简短的内容。结论：在欧洲和北美以外的地区存在提高SM使用的机会。肿瘤DOLs可提高SM内容质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future oncology ONCOLOGY-

CiteScore

5.40

自引率

3.00%

发文量

335

审稿时长

4-8 weeks

期刊介绍： Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.